BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2022 3:45:24 PM | Browse: 257 | Download: 471
 |
Received |
|
2022-03-27 10:25 |
|
Peer-Review Started |
|
2022-03-27 10:26 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-05-11 21:19 |
|
Revised |
|
2022-06-06 05:59 |
|
Second Decision |
|
2022-08-04 02:54 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-08-05 21:45 |
|
Articles in Press |
|
2022-08-05 21:45 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-08-14 10:59 |
|
Typeset the Manuscript |
|
2022-09-01 07:49 |
|
Publish the Manuscript Online |
|
2022-09-09 15:45 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Effectiveness and safety of COVID-19 vaccines in patients with diabetes as factors for vaccine hesitancy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Georgi Vasilev, Plamena Kabakchieva, Dimitrina Miteva, Hristiana Batselova and Tsvetelina Velikova |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Tsvetelina Velikova, MD, PhD, Assistant Professor, Chief Doctor, Department of Clinical Immunology, University Hospital Lozenetz, Kozyak 1 Str., Sofia 1407, Bulgaria. tsvelikova@medfac.mu-sofia.bg |
| Key Words |
COVID-19; COVID-19 vaccines; Diabetes; Vaccine effectiveness; Vaccine; Vaccine hesitancy |
| Core Tip |
Identifying diabetes mellitus as a crucial contributor to coronavirus disease 2019 (COVID-19) mortality enables us to intervene and attempt to reduce the deleterious effects of the infection on vulnerable diabetic individuals. This review highlights published research on the effectiveness of vaccination against COVID-19 and related adverse events. Despite data of a notable decrease in the immune response to vaccination of diabetic patients, studies point out the importance of strict glycemic control to achieve adequate immunity against severe acute respiratory syndrome coronavirus 2 and the need to prioritize people with diabetes for the administration of booster doses. Regarding adverse events, none were increased in frequency in the diabetic population, except sporadic transient hyperglycemia observed post-vaccination. |
| Publish Date |
2022-09-09 15:45 |
| Citation |
Vasilev G, Kabakchieva P, Miteva D, Batselova H, Velikova T. Effectiveness and safety of COVID-19 vaccines in patients with diabetes as factors for vaccine hesitancy. World J Diabetes 2022; 13(9): 738-751 |
| URL |
https://www.wjgnet.com/1948-9358/full/v13/i9/738.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v13.i9.738 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
